<p>Definitive Healthcare（納斯達克代碼：DH - 獲取免費報告）在週四更新了 2026 年第二季度的收益指引。該公司提供的每股收益（EPS）指引為 0.030-0.040，而市場共識預期為 0.030。該公司發佈的收入指引為 5500 萬美元至 5600 萬美元，而市場共識收入預期為 5570 萬美元。Definitive Healthcare 還將其 2026 財年的指引更新為 0.160-0.19 EPS。</p>
<p>獲取 <strong>Definitive Healthcare</strong> 的提醒：</p>
<h2>Definitive Healthcare 股價表現</h2>
<p>週四，Definitive Healthcare 的股票下跌了 0.02 美元，報 0.92 美元。該公司的交易量為 331,909 股，而其平均交易量為 354,274 股。該公司的市值為 9723 萬美元，市盈率為-0.74，市盈率增長比率為 84.12，貝塔係數為 1.34。Definitive Healthcare 的一年最低價為 0.90 美元，一年最高價為 4.70 美元。該公司的債務與股本比率為 0.41，速動比率為 1.64，流動比率為 1.64。該公司的 50 日移動平均價格為 1.10 美元，200 日移動平均價格為 1.99 美元。</p>
<p>Definitive Healthcare（納斯達克代碼：DH - 獲取免費報告）最近在 5 月 7 日發佈了季度財報。該公司報告的每股收益（EPS）為 0.06 美元，超出分析師的共識預期 0.03 美元。Definitive Healthcare 的股本回報率為 2.63%，淨利潤率為-57.52%。該公司季度收入為 5593 萬美元，而市場共識預期為 5502 萬美元。Definitive Healthcare 將其 2026 年第二季度的指引設定為 0.030-0.040 EPS，2026 財年的指引設定為 0.160-0.19 EPS。整體來看，賣方分析師預計 Definitive Healthcare 在當前財年將發佈 0.01 美元的每股收益。</p>
<h2>分析師評級升級與降級</h2>
<p>DH 成為多家研究分析師報告的主題。Canaccord Genuity Group 在 2 月 27 日的研究報告中將 Definitive Healthcare 的目標股價從 4.00 美元下調至 3.00 美元，並對該股票給予 “持有” 評級。巴克萊在 3 月 30 日的研究報告中將 Definitive Healthcare 的目標股價從 2.75 美元下調至 1.00 美元，並對該公司給予 “減持” 評級。華爾街 Zen 在 3 月 14 日的研究報告中將 Definitive Healthcare 的評級從 “持有” 上調至 “買入”。Weiss Ratings 在 1 月 21 日的研究報告中重新發布了 Definitive Healthcare 的 “賣出（d-）” 評級。最後，Zacks Research 在 4 月 28 日的研究報告中將 Definitive Healthcare 的評級從 “強烈賣出” 上調至 “持有”。一位投資分析師給予該股票 “強烈買入” 評級，一位給予 “買入” 評級，五位給予 “持有” 評級，三位給予 “賣出” 評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “持有”，平均目標股價為 3.27 美元。</p>
<p><strong>查看我們關於 Definitive Healthcare 的最新報告</strong></p>
<h2>機構資金流入與流出</h2>
<p>幾家機構投資者和對沖基金最近調整了對 DH 的持股。高盛集團在第一季度將其在 Definitive Healthcare 的持股增加了 564.2%。高盛集團目前擁有 8716725 股該公司的股票，價值 25191000 美元，此前在此期間又購買了 7404363 股。Dimensional Fund Advisors LP 在第三季度將其在 Definitive Healthcare 的持股增加了 1.6%。Dimensional Fund Advisors LP 目前擁有 2073197 股該公司的股票，價值 8417000 美元，此前在此期間又購買了 33612 股。Arrowstreet Capital Limited Partnership 在第三季度將其在 Definitive Healthcare 的持股增加了 11.7%。Arrowstreet Capital Limited Partnership 目前擁有 1216007 股該公司的股票，價值 4937000 美元，此前在上個季度又收購了 127055 股。美國銀行在第二季度將其在 Definitive Healthcare 的持股增加了 23.7%。美國銀行目前擁有 769397 股該公司的股票，價值 3001000 美元，此前在此期間又收購了 147599 股。最後，Inspire Investing LLC 在第四季度將其在 Definitive Healthcare 的持股增加了 505.7%。Inspire Investing LLC 目前擁有 698967 股該公司的股票，價值 2006000 美元，此前在上個季度又收購了 583562 股。機構投資者和對沖基金持有該公司 98.67% 的股票。</p>
<h2>關於 Definitive Healthcare</h2>
<p>（獲取免費報告）</p>
<p>Definitive Healthcare（納斯達克代碼：DH）是醫療服務提供者、組織及治療患者的專業人員的情報和分析的領先提供商。通過其基於雲的平台，該公司從多個來源匯總數據，包括索賠、政府登記、商業備案和專有研究，以提供醫療保健領域的統一視圖。其解決方案使生命科學公司、醫療服務提供者、支付方和諮詢公司能夠識別市場機會，優化銷售和營銷工作，提高運營效率，並支持更好的患者結果。</p>
<p>該公司的旗艦產品是一個基於訂閲的數據平台，提供關於醫生、醫院、健康系統和後期護理設施的詳細資料。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票比 Definitive Healthcare 更具投資價值</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Definitive Healthcare 嗎？</h2>
<p>在你考慮 Definitive Healthcare 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Definitive Healthcare 並不在名單上。</p>
<p>雖然 Definitive Healthcare 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Definitive Healthcare（納斯達克代碼：DH）更新了其 2026 年第二季度的盈利指引，預計每股收益（EPS）為 0.030-0.040，略高於市場共識預期的 0.030。收入指引設定在 5500 萬至 5600 萬美元之間，低於市場共識的 5570 萬美元。該公司還修訂了 2026 財年的每股收益指引至 0.160-0.19。儘管最近股價下跌至 0.92 美元，分析師們仍維持 “持有” 的共識評級，平均目標價為 3.27 美元。機構投資者持有該公司 98.67% 的股份，顯示出強勁的機構支持</p>

<p>Definitive Healthcare (NASDAQ:DH - Get Free Report) updated its second quarter 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.030-0.040 for the period, compared to the consensus estimate of 0.030. The company issued revenue guidance of $55.0 million-$56.0 million, compared to the consensus revenue estimate of $55.7 million. Definitive Healthcare also updated its FY 2026 guidance to 0.160-0.19 EPS.</p>
<div class="lb-trans"><p>Definitive Healthcare（納斯達克代碼：DH - 獲取免費報告）在週四更新了 2026 年第二季度的收益指引。該公司提供的每股收益（EPS）指引為 0.030-0.040，而市場共識預期為 0.030。該公司發佈的收入指引為 5500 萬美元至 5600 萬美元，而市場共識收入預期為 5570 萬美元。Definitive Healthcare 還將其 2026 財年的指引更新為 0.160-0.19 EPS。</p>
</div><p>Get <strong>Definitive Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Definitive Healthcare</strong> 的提醒：</p>
</div><h2>Definitive Healthcare Price Performance</h2>
<div class="lb-trans"><h2>Definitive Healthcare 股價表現</h2>
</div><p>Shares of Definitive Healthcare stock traded down $0.02 on Thursday, hitting $0.92. The company's stock had a trading volume of 331,909 shares, compared to its average volume of 354,274. The company has a market capitalization of $97.23 million, a price-to-earnings ratio of -0.74, a price-to-earnings-growth ratio of 84.12 and a beta of 1.34. Definitive Healthcare has a 1 year low of $0.90 and a 1 year high of $4.70. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.64 and a current ratio of 1.64. The firm has a fifty day moving average price of $1.10 and a 200-day moving average price of $1.99.</p>
<div class="lb-trans"><p>週四，Definitive Healthcare 的股票下跌了 0.02 美元，報 0.92 美元。該公司的交易量為 331,909 股，而其平均交易量為 354,274 股。該公司的市值為 9723 萬美元，市盈率為-0.74，市盈率增長比率為 84.12，貝塔係數為 1.34。Definitive Healthcare 的一年最低價為 0.90 美元，一年最高價為 4.70 美元。該公司的債務與股本比率為 0.41，速動比率為 1.64，流動比率為 1.64。該公司的 50 日移動平均價格為 1.10 美元，200 日移動平均價格為 1.99 美元。</p>
</div><p>Definitive Healthcare (NASDAQ:DH - Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.03 by $0.03. Definitive Healthcare had a positive return on equity of 2.63% and a negative net margin of 57.52%.The company had revenue of $55.93 million for the quarter, compared to the consensus estimate of $55.02 million. Definitive Healthcare has set its Q2 2026 guidance at 0.030-0.040 EPS and its FY 2026 guidance at 0.160-0.19 EPS. As a group, sell-side analysts anticipate that Definitive Healthcare will post 0.01 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Definitive Healthcare（納斯達克代碼：DH - 獲取免費報告）最近在 5 月 7 日發佈了季度財報。該公司報告的每股收益（EPS）為 0.06 美元，超出分析師的共識預期 0.03 美元。Definitive Healthcare 的股本回報率為 2.63%，淨利潤率為-57.52%。該公司季度收入為 5593 萬美元，而市場共識預期為 5502 萬美元。Definitive Healthcare 將其 2026 年第二季度的指引設定為 0.030-0.040 EPS，2026 財年的指引設定為 0.160-0.19 EPS。整體來看，賣方分析師預計 Definitive Healthcare 在當前財年將發佈 0.01 美元的每股收益。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級升級與降級</h2>
</div><p>DH has been the topic of a number of research analyst reports. Canaccord Genuity Group dropped their price target on shares of Definitive Healthcare from $4.00 to $3.00 and set a &#34;hold&#34; rating on the stock in a research note on Friday, February 27th. Barclays reduced their price objective on shares of Definitive Healthcare from $2.75 to $1.00 and set an &#34;underweight&#34; rating for the company in a research report on Monday, March 30th. Wall Street Zen upgraded shares of Definitive Healthcare from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, March 14th. Weiss Ratings reissued a &#34;sell (d-)&#34; rating on shares of Definitive Healthcare in a research note on Wednesday, January 21st. Finally, Zacks Research raised shares of Definitive Healthcare from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday, April 28th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, five have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of &#34;Hold&#34; and an average price target of $3.27.</p>
<div class="lb-trans"><p>DH 成為多家研究分析師報告的主題。Canaccord Genuity Group 在 2 月 27 日的研究報告中將 Definitive Healthcare 的目標股價從 4.00 美元下調至 3.00 美元，並對該股票給予 “持有” 評級。巴克萊在 3 月 30 日的研究報告中將 Definitive Healthcare 的目標股價從 2.75 美元下調至 1.00 美元，並對該公司給予 “減持” 評級。華爾街 Zen 在 3 月 14 日的研究報告中將 Definitive Healthcare 的評級從 “持有” 上調至 “買入”。Weiss Ratings 在 1 月 21 日的研究報告中重新發布了 Definitive Healthcare 的 “賣出（d-）” 評級。最後，Zacks Research 在 4 月 28 日的研究報告中將 Definitive Healthcare 的評級從 “強烈賣出” 上調至 “持有”。一位投資分析師給予該股票 “強烈買入” 評級，一位給予 “買入” 評級，五位給予 “持有” 評級，三位給予 “賣出” 評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “持有”，平均目標股價為 3.27 美元。</p>
</div><p><strong>Check Out Our Latest Report on Definitive Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Definitive Healthcare 的最新報告</strong></p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入與流出</h2>
</div><p>Several institutional investors and hedge funds have recently modified their holdings of DH. Goldman Sachs Group Inc. raised its stake in Definitive Healthcare by 564.2% during the first quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company's stock worth $25,191,000 after purchasing an additional 7,404,363 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Definitive Healthcare by 1.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,073,197 shares of the company's stock valued at $8,417,000 after buying an additional 33,612 shares during the period. Arrowstreet Capital Limited Partnership lifted its holdings in Definitive Healthcare by 11.7% in the third quarter. Arrowstreet Capital Limited Partnership now owns 1,216,007 shares of the company's stock valued at $4,937,000 after acquiring an additional 127,055 shares during the last quarter. Bank of America Corp DE grew its position in Definitive Healthcare by 23.7% in the second quarter. Bank of America Corp DE now owns 769,397 shares of the company's stock worth $3,001,000 after acquiring an additional 147,599 shares during the period. Finally, Inspire Investing LLC increased its stake in Definitive Healthcare by 505.7% during the fourth quarter. Inspire Investing LLC now owns 698,967 shares of the company's stock worth $2,006,000 after acquiring an additional 583,562 shares during the last quarter. Institutional investors and hedge funds own 98.67% of the company's stock.</p>
<div class="lb-trans"><p>幾家機構投資者和對沖基金最近調整了對 DH 的持股。高盛集團在第一季度將其在 Definitive Healthcare 的持股增加了 564.2%。高盛集團目前擁有 8716725 股該公司的股票，價值 25191000 美元，此前在此期間又購買了 7404363 股。Dimensional Fund Advisors LP 在第三季度將其在 Definitive Healthcare 的持股增加了 1.6%。Dimensional Fund Advisors LP 目前擁有 2073197 股該公司的股票，價值 8417000 美元，此前在此期間又購買了 33612 股。Arrowstreet Capital Limited Partnership 在第三季度將其在 Definitive Healthcare 的持股增加了 11.7%。Arrowstreet Capital Limited Partnership 目前擁有 1216007 股該公司的股票，價值 4937000 美元，此前在上個季度又收購了 127055 股。美國銀行在第二季度將其在 Definitive Healthcare 的持股增加了 23.7%。美國銀行目前擁有 769397 股該公司的股票，價值 3001000 美元，此前在此期間又收購了 147599 股。最後，Inspire Investing LLC 在第四季度將其在 Definitive Healthcare 的持股增加了 505.7%。Inspire Investing LLC 目前擁有 698967 股該公司的股票，價值 2006000 美元，此前在上個季度又收購了 583562 股。機構投資者和對沖基金持有該公司 98.67% 的股票。</p>
</div><h2>About Definitive Healthcare</h2>
<div class="lb-trans"><h2>關於 Definitive Healthcare</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Definitive Healthcare NASDAQ: DH is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.</p>
<div class="lb-trans"><p>Definitive Healthcare（納斯達克代碼：DH）是醫療服務提供者、組織及治療患者的專業人員的情報和分析的領先提供商。通過其基於雲的平台，該公司從多個來源匯總數據，包括索賠、政府登記、商業備案和專有研究，以提供醫療保健領域的統一視圖。其解決方案使生命科學公司、醫療服務提供者、支付方和諮詢公司能夠識別市場機會，優化銷售和營銷工作，提高運營效率，並支持更好的患者結果。</p>
</div><p>The company's flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.</p>
<div class="lb-trans"><p>該公司的旗艦產品是一個基於訂閲的數據平台，提供關於醫生、醫院、健康系統和後期護理設施的詳細資料。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Definitive Healthcare</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Definitive Healthcare 更具投資價值</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Definitive Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Definitive Healthcare 嗎？</h2>
</div><p>Before you consider Definitive Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Definitive Healthcare 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Definitive Healthcare 並不在名單上。</p>
</div><p>While Definitive Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Definitive Healthcare 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Definitive Healthcare (NASDAQ:DH) Updates Q2 2026 Earnings Guidance

Market Beat

Definitive Healthcare

巴克萊銀行

高盛

美國銀行

GS Hldg R

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

Definitive Healthcare（納斯達克股票代碼：DH）更新了 2026 年第二季度的收益指引